Deutsche Bank
CRL icon

Deutsche Bank’s Charles River Laboratories CRL Stock Holding History

Deutsche Bank’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-785
Closed -$8K – 5899
2014
Q1 		$8K Buy
+785
New +$45.8K ﹤0.01% 5082

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deutsche Bank's CRL Position: Q1 2026 in Review

Deutsche Bank increased its Charles River Laboratories (CRL) stake by 46% in Q1 2026, buying an estimated $16.2M and bringing the position to 275,381 shares worth $47.5M. The position accounts for 0.02% of the portfolio, ranked #636.

Deutsche Bank first reported a position in CRL in Q2 2013 and has held it in 52 quarters since. The position peaked at $94.1M in Q3 2021. 558 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Deutsche Bank held 275,381 shares of Charles River Laboratories worth $47.5M as of Q1 2026.
  • Deutsche Bank bought 87,285 Charles River Laboratories shares in Q1 2026, an estimated $16.2M.
  • Charles River Laboratories made up 0.02% of Deutsche Bank's portfolio in Q1 2026, its #636 holding.
  • Deutsche Bank first reported a position in Charles River Laboratories in Q2 2013 and has held it in 52 quarters since.
  • Deutsche Bank's Charles River Laboratories position peaked at $94.1M in Q3 2021.
  • 558 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.